Koji Nakashima Selected Research

Koji Nakashima Research Topics

Disease

7	Neoplasms (Cancer) 09/2021 - 05/2008
4	Adenocarcinoma 09/2021 - 10/2017
3	Carcinoma (Carcinomatosis) 02/2020 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 05/2022 - 05/2008
2	Neoplasm Metastasis (Metastasis) 09/2021 - 08/2017
2	Type 2 Diabetes Mellitus (MODY) 11/2020 - 01/2018
2	Insulin Resistance 01/2020 - 03/2015
2	Stomach Neoplasms (Stomach Cancer) 12/2018 - 12/2008
2	Glucose Intolerance 03/2015 - 01/2009
2	Hepatocellular Carcinoma (Hepatoma) 05/2013 - 03/2006
1	Vitamin K Deficiency 05/2022
1	Colitis 05/2022
1	Gastrointestinal Hemorrhage (Hematochezia) 05/2022
1	Short Bowel Syndrome 05/2022
1	Nocturia 01/2021
1	Hyperglycemia 11/2020
1	Diabetes Mellitus 11/2020
1	Non-alcoholic Fatty Liver Disease 11/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020
1	Prostatic Neoplasms (Prostate Cancer) 10/2020
1	Pathologic Constriction (Stenosis) 02/2020
1	Lung Neoplasms (Lung Cancer) 02/2020
1	Crohn Disease (Crohn's Disease) 06/2019
1	Hepatoblastoma 12/2017
1	Leiomyosarcoma 08/2017
1	Phototoxic Dermatitis (Phototoxicity) 03/2017
1	Esophageal Neoplasms (Esophageal Cancer) 01/2017
1	Fatty Liver 07/2016
1	Colitis-Associated Neoplasms 06/2016
1	Mesothelioma 12/2012
1	Hypertension (High Blood Pressure) 05/2010
1	Nausea 05/2010
1	Hypertensive Encephalopathy 05/2010
1	Posterior Leukoencephalopathy Syndrome 05/2010
1	Meningitis 04/2008
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2006
1	Dermatomyositis (Dermatopolymyositis) 03/2006

Drug/Important Bio-Agent (IBA)

3	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2020 - 10/2017
2	ErbB Receptors (EGF Receptor)IBA 05/2022 - 05/2008
2	Panitumumab (Vectibix)FDA Link 05/2022 - 05/2008
2	Photosensitizing Agents (Photosensitizers)IBA 02/2020 - 03/2017
2	Talaporfin (talaporfin sodium)IBA 02/2020 - 01/2017
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 02/2020 - 03/2017
2	Insulin (Novolin)FDA Link 01/2020 - 01/2009
1	Monoclonal AntibodiesIBA 05/2022
1	Vitamin K FDA Link 05/2022
1	amsonic acid (DAS)IBA 01/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2021
1	Pioglitazone (Actos)FDA Link 11/2020
1	dapagliflozinIBA 11/2020
1	AdiponectinIBA 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 11/2020
1	glimepiride (Amarel)FDA LinkGeneric 11/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 11/2020
1	Gemcitabine FDA Link 10/2020
1	PlatinumIBA 10/2020
1	perfluoro- 2,2,2',2'- tetramethyl- 4,4'- bis(1,3- dioxolane)IBA 02/2020
1	Blood Glucose (Blood Sugar)IBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 06/2019
1	AdrenomedullinIBA 06/2019
1	SteroidsIBA 06/2019
1	Infliximab (Remicade)FDA Link 06/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2018
1	XenobioticsIBA 12/2017
1	Leucovorin (Folinic Acid)FDA Link 10/2017
1	Fluorouracil (Carac)FDA LinkGeneric 10/2017
1	Alanine Transaminase (SGPT)IBA 07/2016
1	DNA (Deoxyribonucleic Acid)IBA 05/2013
1	WastewaterIBA 05/2013
1	Diltiazem (Cardizem)FDA LinkGeneric 05/2010
1	Antihypertensive Agents (Antihypertensives)IBA 05/2010
1	S-1 plus cisplatinIBA 12/2008
1	Irinotecan (Camptosar)FDA LinkGeneric 12/2008
1	Cisplatin (Platino)FDA LinkGeneric 12/2008
1	Bevacizumab (Avastin)FDA Link 05/2008
1	Cetuximab (Erbitux)FDA Link 05/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2008
1	Linezolid (Zyvox)FDA Link 04/2008
1	Vancomycin FDA LinkGeneric 04/2008

Therapy/Procedure

10	Drug Therapy (Chemotherapy) 05/2022 - 05/2008
6	Therapeutics 06/2019 - 03/2006
3	Photochemotherapy (Photodynamic Therapy) 02/2020 - 01/2017
2	Semiconductor Lasers 02/2020 - 01/2017
1	Adjuvant Chemotherapy 09/2021
1	Endoscopes 02/2020
1	Intravenous Injections 02/2020
1	Remission Induction 06/2019
1	Nursing Care 03/2017
1	Intravenous Administration 03/2017
1	Lymph Node Excision (Lymph Node Dissection) 01/2017
1	Chemoradiotherapy 01/2017
1	Diet Therapy (Therapy, Diet) 03/2015
1	Bioreactors (Bioreactor) 05/2013